Theranostics · 2022 · 27 citations · 49 references
MedicineBioengineeringOncologyBiomedical ImagingBiomedical OpticsMetastasisCancer NanomedicineLymph Node MetastasisNanomedicineSentinel Lymph Node BiopsySentinel Lymph Node MappingTargeted Imaging AgentsFluorescence Imaging ProbesFluorescence ProbesFluorescence-guided SurgeryLanthanide-doped NanoparticlesNear-infrared Fluorescence ImagingNear-infrared ProbesRatiometric Fluorescence ImagingSentinel Lymph Node Identification
Sentinel lymph node (SLN) biopsy is the key diagnostic procedure to determine tumor metastasis and treatment plan. Current SLN biopsy has considerable drawbacks in that SLNs (both malignant and normal) must be removed by navigation surgery, followed by a time-consuming pathological examination. The selective, non-invasive, and real-time diagnosis of metastatic status in SLNs is becoming essential. Methods: Here, we design two lanthanide-doped nanoparticles as a pair of NIR-II ratiometric fluorescence probes, one of which is conjugated with tumor-targeting moiety, while the other is conjugated with PEG as an internal reference. The NIR-II ratiometric fluorescence signal (I1060 nm/I1525 nm) from two well-separated channels were used to identify the tumor-draining SLNs. The precise navigation surgery of metastatic SLNs was performed and we further evaluated their surgery outcomes.
49
In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
Chao Wang, Wujin Sun, Yanqi Ye et al. · Nature Biomedical Engineering · 2017 · 515 citations
Medicine, Hematology, Oncology +13